About Astrea Bioseparations
Astrea Bioseparations is a company based in Cambridge (United Kingdom) founded in 1987 was acquired by Biotage in February 2023. It operates as a Direct-to-Consumer (D2C), and Professional Services. Astrea Bioseparations has completed 1 acquisition, including Delta Precision. Astrea Bioseparations offers products and services including AstreAdept® Chromatography Capsules, LentiHERO®, ExoHERO®, pDNAHERO®, and PuraBead® Resins. Astrea Bioseparations operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others.
- Headquarter Cambridge, United Kingdom
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Astrea Bioseparations
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Biotage
(Feb 28, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Astrea Bioseparations
Astrea Bioseparations offers a comprehensive portfolio of products and services, including AstreAdept® Chromatography Capsules, LentiHERO®, ExoHERO®, pDNAHERO®, and PuraBead® Resins. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Capsules are provided for advanced bioprocessing purification needs.
Tools are offered for high lentiviral vector recovery.
Capsules are designed for extracellular vesicle isolation efficiency.
Solutions are provided for streamlined plasmid DNA processing.
Resins are developed for various chromatography purification methods.
Unlock access to complete
Funding Insights of Astrea Bioseparations
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Astrea Bioseparations
Astrea Bioseparations has secured backing from 1 investor. Prominent investors backing the company include Biotage. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Astrea Bioseparations
Astrea Bioseparations has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Delta Precision. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufacturing and design services for chromatography products are provided.
|
2004 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Astrea Bioseparations
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Astrea Bioseparations Comparisons
Competitors of Astrea Bioseparations
Astrea Bioseparations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic device and kits
|
|
| domain | founded_year | HQ Location |
Molecular biology reagents and kits are supplied for research applications.
|
|
| domain | founded_year | HQ Location |
Research services, reagents, and kits for biotech applications are provided.
|
|
| domain | founded_year | HQ Location |
Bioreagents and assay kits are developed, with preclinical services provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Astrea Bioseparations
Frequently Asked Questions about Astrea Bioseparations
When was Astrea Bioseparations founded?
Astrea Bioseparations was founded in 1987.
Where is Astrea Bioseparations located?
Astrea Bioseparations is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Who is the current CEO of Astrea Bioseparations?
Terry Pizzie is the current CEO of Astrea Bioseparations.
What does Astrea Bioseparations do?
Astrea Bioseparations is focused on delivering advanced bioseparation technologies for bioprocessing applications. The company operates within the biotechnology sector, offering solutions for cell and gene therapy, recombinant proteins, and plasma proteins. Products such as chromatography capsules, resins, and purification tools are developed to support process development and commercialization. With over 30 years of expertise, operations are geared towards meeting FDA and EMA standards. Innovation is driven by a dedicated RD team to address dynamic industry needs for speed and efficiency in delivering life-improving therapies.
Who are the top competitors of Astrea Bioseparations?
Astrea Bioseparations's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
What products or services does Astrea Bioseparations offer?
Astrea Bioseparations offers AstreAdept® Chromatography Capsules, LentiHERO®, ExoHERO®, pDNAHERO®, and PuraBead® Resins.
How many acquisitions has Astrea Bioseparations made?
Astrea Bioseparations has made 1 acquisition, including Delta Precision.
Who are Astrea Bioseparations's investors?
Astrea Bioseparations has 1 investor. Key investors include Biotage.